NCT01865786View on ClinicalTrials.gov

A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication

CompletedOBSERVATIONAL

Enrollment

99

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

March 13, 2018

Study Completion Date

March 13, 2018

Conditions

HIV Infection

Trial Locations (1)

28405

Antiretroviral Pregnancy Registry, Wilmington

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY

NCT01865786 - A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication | Biotech Hunter | Biotech Hunter